Alqattan AS, Ibrahim AH, Al Abdrabalnabi AA, AlShahrani AA. Staged surgical approach for metastatic GIST, how far should we go? Case report.
Int J Surg Case Rep 2021;
84:106044. [PMID:
34225062 PMCID:
PMC8259298 DOI:
10.1016/j.ijscr.2021.106044]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2021] [Revised: 05/03/2021] [Accepted: 05/21/2021] [Indexed: 02/03/2023] Open
Abstract
Introduction
Gastrointestinal stromal tumor (GIST) is an uncommon mesenchymal neoplasm that commonly arises from the stomach and proximal small intestine but can develop in any part of the gastrointestinal tract. The disease can range from primary localized to an advanced metastatic unresectable disease in up to 30% of patients. Usually, metastasis involves the liver, peritoneum, and occasionally the lungs. The current standard treatment of localized resectable tumors is complete oncological resection, while advanced metastatic GISTs treatment remains contentious.
Case presentation
We report a case of a 34 years old pregnant female presenting with a 3 days history of multiple episodes of hematemesis and melena. Laboratory investigations were unremarkable except for severe anemia (Hgb 4.4 g/dL). After further investigations a diagnosis of duodenal GIST (DGIST) with liver metastasis was made. She received and showed good response to neoadjuvant Imatinib therapy, which was followed by a successful 2-stage surgery in the form of extended right hepatectomy and Whipple procedure with a good survival.
Clinical dissection
The evolution of Imatinib had a tremendous impact on surgery in metastatic GIST even in initially unresectable cases, thereby providing a better survival. However, the duration of neoadjuvant Imatinib course and the matter of resistance are still unclear those necessitating the use of different agents or the surgical approach.
Conclusion
Although with the advancements in surgical approaches and perioperative care, liver resection might be a curative option. The role of surgery in advanced GIST remains a controversial matter that needs critical selection of cases based on further future research.
GIST is considered a relatively rare entity, accounting for only 1% of all primary gastrointestinal tumors with the incidence being 10-13 per million population per year.
We present a case of a 34 pregnant female presenting with vomiting blood and passing melena, which after further examination and investigation was revealed to be due to a duodenal GIST.
The evolution of Imatinib had a tremendous impact on surgery in metastatic GIST even in initially unresectable cases.
Collapse